Importing Controlled Substances and Scheduled Poisons into Malaysia: Permits, Documentation, and Transit Requirements

Pharmaceutical importers who assume an NPRA Import Licence is sufficient authority for everything in their import programme are not the majority, but they are not rare either. The licence covers registered pharmaceutical products under the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984. It does not, on its own, cover controlled substances under the Dangerous Drugs Act 1952 or psychotropic substances regulated under the Poisons Act 1952. Both regimes layer additional permits, additional documentation, and additional storage and handling requirements on top of the Import Licence, and standard pharmaceutical cargo policies frequently sub-limit or exclude these categories unless a handling endorsement is purchased at placement.

This guide walks through the two regulatory regimes, the permit hierarchy that sits above the NPRA Import Licence, the documentation that travels with the cargo, and the cargo insurance gap that surfaces when controlled substances arrive damaged or missing without the right endorsements in place.

Key Facts: Importing Controlled Substances and Scheduled Poisons into Malaysia

Which two Malaysian laws govern controlled substances and scheduled poisons in import? The Dangerous Drugs Act 1952 (Act 234, revised 1980) governs opium, dangerous drugs, and related narcotics. The Poisons Act 1952 (Act 366, revised 1989) governs scheduled poisons including psychotropic substances, with the Poisons List in the First Schedule classifying substances into Groups A to F.

What permit does an importer need under the Dangerous Drugs Act 1952? An Import Authorization, issued under Section 20 of the Dangerous Drugs Act 1952 on Form C, granted by the Minister of Health subject to such conditions as he may deem fit. The authorisation is issued by the Pharmacy Enforcement Division of the Ministry of Health.

What permit does an importer need for psychotropic substances under the Poisons Act 1952? An Import Authorization issued under Section 30 of the Poisons Act 1952 and Regulation 4(1) of the Poisons (Psychotropic Substances) Regulations 1989. Psychotropic substances are listed in the Third Schedule of the Poisons Act 1952.

Who can hold the Import Authorization for controlled substances or psychotropic substances? A holder of a valid Type A Poison Licence (Wholesale). The Type A licence is issued to a pharmacist and covers the import, storage, and dealing of all poisons by wholesale and retail, by wholesale only, or by retail only. Type B licences, issued to responsible officers of companies, do not cover Group A poisons.

What is the cargo insurance exposure on controlled substances? Standard pharmaceutical cargo policies frequently apply sub-limits to controlled substances under the Dangerous Drugs Act 1952 and Schedule 1 and Schedule 2 poisons under the Poisons Act 1952, or exclude them entirely unless a handling endorsement is purchased. Importers with mixed cargo discover this at claim rather than at placement.

Which substances fall within the Group A restriction under the Poisons Act 1952? Group A Poison cannot be sold or supplied by wholesale or retail except by a licensed wholesaler to a licensed pharmacist or to another licensed wholesaler. The First Schedule of the Poisons Act 1952 sets out the complete Poisons List, with Group B and Group C carrying their own prescription and supply restrictions.

For the foundational regulatory frameworks, see the pharmaceutical imports cargo insurance cluster hub, the Pharmaceutical & Medical Devices Cargo Insurance industry page, and Institute Cargo Clauses for the cover form. For the underlying legal framework of marine insurance, see Marine Insurance Act 1906.

Resource: Cargo Insurance Coverage Audit

Take the 9-question Cargo Insurance Coverage Audit to score your controlled-drug and scheduled-poison cargo cover against the handling endorsement baseline. Free, no signup wall.

The Two Regulatory Acts and How They Interact

Controlled substances and scheduled poisons in Malaysia are governed by two pieces of primary legislation working in parallel.

The Dangerous Drugs Act 1952 (Act 234, revised 1980) regulates opium and the wider class of dangerous drugs, including narcotic and certain psychotropic substances. The Act's scope covers import, export, manufacture, sale, possession, and use. The First Schedule of the Act lists dangerous drugs to which the Act applies. Section 20 governs the authorisation required to import dangerous drugs into Malaysia.

The Poisons Act 1952 (Act 366, revised 1989) regulates poisons listed in the First Schedule, which sets out the Poisons List. Part I of the First Schedule lists poisons by Groups A, B, C, D, E, and F. Part II lists poisons that are not classified by group. The Third Schedule, referenced under Section 30, separately lists psychotropic substances that are subject to the Poisons (Psychotropic Substances) Regulations 1989.

The interaction matters because a given pharmaceutical product can fall within either regime, or both. Opioid analgesics, for example, may sit within the Dangerous Drugs Act 1952 framework, with the additional Type A Poison Licence requirement flowing through from the Poisons Act 1952. Many psychotropic medications fall within the Third Schedule under the Poisons Act 1952 directly. The practical guidance is to map every product on the importer's list against both Acts before assuming the NPRA Import Licence is the only authority required.

The Scheduled Poisons Group System

Under the First Schedule of the Poisons Act 1952, scheduled poisons are classified into six groups in Part I, with each group carrying its own sale, supply, and handling rules.

The Third Schedule [Section 30] of the Poisons Act 1952 separately lists psychotropic substances. The Poisons (Psychotropic Substances) Regulations 1989, which came into force on 15 April 1989, set the specific authorisation regime under Regulation 4(1) for the import, export, manufacture, sale, supply, and possession of these substances.

For practical importer mapping, the key question is whether each product on the licence list falls within Group A (highest wholesale restriction), within the psychotropic substances Third Schedule (separate authorisation regime), or within the Dangerous Drugs Act 1952 (Form C Import Authorization). These are not mutually exclusive; some products fall within two or all three regimes simultaneously.

For NPRA-licenced importers moving controlled substances and scheduled poisons, Marine Cargo Open Cover with a controlled substances handling endorsement is the working placement structure; for high-value or per-consignment movements, Specialist High-Value Transit Insurance applies. For the industry view, see Pharmaceutical & Medical Devices Cargo Insurance.

The Permit Hierarchy: What Sits Above the NPRA Import Licence

For a pharmaceutical importer handling controlled substances or scheduled poisons, the permit hierarchy stacks as follows.

Layers one and two are the base regime that applies to every pharmaceutical importer. Layers three, four, and five apply only where the cargo includes scheduled poisons, psychotropic substances, or dangerous drugs respectively. Where multiple categories of cargo move on the same consignment, multiple layered authorisations may be required for a single shipment.

Type A versus Type B Poison Licence

The Poisons Act 1952 sets up several licence types under the Second Schedule of the Poison Regulations 1952. For pharmaceutical importers, the two that matter most are Type A and Type B.

A Type A Poison Licence is issued to a pharmacist and covers the import, storage, and dealing of all poisons (including Group A) by wholesale and retail, by wholesale only, or by retail only. This is the licence that pharmaceutical importers handling scheduled poisons need to have in place, held by an appointed pharmacist who is named on the NPRA Import Licence application.

A Type B Licence is issued to any person whom the Licensing Officer considers fit and proper, or to a responsible officer of a company incorporated under the Companies Act, to import, store, and sell by wholesale such poisons (not being a Group A Poison) as may be specified in the licence. Type B does not cover Group A poisons, which is the binding constraint that pushes pharmaceutical importers handling the highest-restriction scheduled poisons towards the Type A route.

For pharmaceutical importer-distributors handling any Group A poison or any Schedule 3 psychotropic substance, the practical answer is to appoint a Type A Poison Licence-holding pharmacist. The same individual must hold the Identity Card or Passport referenced on the NPRA Import Licence application if Scheduled Poisons are involved on the licence list, per the NPRA Guideline on Application of Manufacturer's, Import and Wholesaler's Licenses for Registered Products (3rd Edition, March 2025).

The Import Authorization: Per-Consignment Permit

Where the NPRA Import Licence and the Type A Poison Licence are annual operational licences, the Section 20 Form C Authorization (for dangerous drugs) and the Section 30 Authorization (for psychotropic substances) are per-consignment permits. Each individual import consignment requires its own authorisation in advance of shipment.

The Pharmacy Enforcement Division of the Ministry of Health issues these authorisations. The Pharmacy Services Programme of MOH publishes the application guidance and runs the application channels. For precursors and certain controlled substances, MOH issues electronic permit approvals through an online web-based system called e-Permit. For dangerous drugs and psychotropic substances, printed authorisations are issued.

Psychotropic substances transiting through Malaysia from a country which is a party to the United Nations Convention on Psychotropic Substances 1971 must be accompanied by a valid and subsisting export authorisation duly issued by the competent authority of the exporting country. Malaysia's import authorisation framework is the domestic counterpart of that international Convention obligation.

Documentation That Travels With the Cargo

For a controlled substances or scheduled poisons import consignment, the documentation pack that travels with the cargo, alongside the standard commercial and transport documents, is materially larger than for a general pharmaceutical shipment.

• The applicable Section 20 Form C Import Authorization or Section 30 Import Authorization, in original or certified copy where required.
• The Type A Poison Licence of the appointed pharmacist (where relevant).
• The current NPRA Import Licence with the controlled substance product on the listed annex.
• The originating country export authorisation, where the cargo is psychotropic substance transiting from a state party to the Convention on Psychotropic Substances 1971.
• Temperature monitoring records throughout transit where the substance also falls within the cold chain regime.
• Chain-of-custody handover records at every transshipment, with particular attention to handover at Malaysian customs clearance where Pharmacy Enforcement Division verification may take place.
• The cargo insurance certificate, with a controlled substances handling endorsement explicitly written into the cover scope. For LC-funded controlled substance imports, the certificate must also meet UCP 600 Article 28 requirements: see LC Insurance Certificate Requirements.

Missing documentation on controlled substances can have consequences well beyond the cargo insurance file. The Pharmacy Enforcement Division has the authority to detain consignments at customs, and offences under the Dangerous Drugs Act 1952 and the Poisons Act 1952 carry significant penalties on conviction.

Storage and Handling Conditions in Malaysia

Storage of controlled substances and scheduled poisons in the importer's Malaysian warehouse is subject to the Poisons Regulations 1952, the Dangerous Drugs Regulations, and any conditions imposed on the Import Licence by the Director of Pharmaceutical Services. Typical requirements include:

• Secure storage with restricted access. Dangerous drugs storage typically requires a designated locked area with restricted personnel access and inventory control records.
• Separate inventory accounting for each controlled substance, with reconciliation against in-and-out movements.
• Designated pharmacist oversight of storage and supply, where the importer holds a Type A Poison Licence.
• Premises and store recorded on the NPRA Import Licence application, with changes triggering a new licence application (not an amendment) where Time and Temperature-Sensitive Product conditions are also involved.
• NPRA inspection cycle compliance for the Import Licence and Pharmacy Enforcement Division inspection cycle compliance for the controlled substance authorisations.

Cold chain controlled substances (some psychotropic injections, certain dangerous drugs in specific formulations) sit at the intersection of the controlled substances regime and the Time and Temperature-Sensitive Products regime under GDP. Both the storage requirements and the in-transit conditions need to be met simultaneously.

The Cargo Insurance Gap on Controlled Substances

This is the area where importer expectations and policy reality most often diverge.

Standard pharmaceutical cargo policies are commonly structured around general pharmaceutical product on Institute Cargo Clauses (A) 2009. Controlled substances under the Dangerous Drugs Act 1952 and Schedule 1 and Schedule 2 poisons under the Poisons Act 1952 are frequently treated by underwriters as a different risk class because the cargo is higher value per unit, attracts a higher theft and pilferage risk profile, requires specific handling and security conditions, and exposes the insurer to consequential regulatory issues if the cargo is lost or misdirected.

The practical consequence is one or more of the following on a standard policy:

• Sub-limit per consignment, often well below the actual cargo value, applying specifically to controlled substances or to high-value pharmaceutical product more broadly.
• Exclusion of controlled substances, with cover only restored by a specific endorsement purchased at placement.
• Security warranties requiring the importer to demonstrate specific handling and storage conditions (locked containers, escorted transit, secure warehousing) as a condition of cover.
• Pilferage and theft sub-limits that are tighter for controlled substances than for general pharmaceutical product on the same policy.

Importers with mixed cargo (generics plus controlled analgesics, vaccines plus psychotropics) frequently discover the controlled substances gap at claim rather than at placement, because the gap is in clauses that read past the casual review. The fix is to review controlled substances scope at placement with the underwriter, with the cargo profile information (substance categories, frequency, per-consignment value, origin mix) explicitly stated, and the handling endorsement explicitly written into the cover.

Mixed pharmaceutical cargo? Confirm controlled substances scope before the next shipment.

Voyage arranges specialist marine cargo insurance for NPRA-licensed pharmaceutical importers, with controlled substances handling endorsements negotiated at placement. Request a coverage review at voyagecover.com/#contact-form or WhatsApp Kevin at +60 19 990 2450.

Modal and Routing Considerations for Controlled Substances

Two routing realities affect controlled substance imports into Malaysia in practice.

First, many controlled substances and psychotropic substances move on air freight rather than reefer sea freight, either because volumes are low enough that air freight is economic or because the importer or supplier prefers a shorter transit chain for high-value, high-security cargo. The cargo insurance implications of air freight, including the Montreal Convention 1999 carrier liability cap of 26 SDR per kilogramme of gross weight (effective 28 December 2024 under the ICAO five-year inflation review), apply equally to controlled substance air freight.

Second, the Pharmacy Enforcement Division regime for controlled substance clearance at Malaysian entry points (Port Klang and KLIA being the principal entry points for the categories considered here) typically involves a dedicated verification stage at customs that may extend the practical transit time and the chain-of-custody documentation needed. The cargo policy's clauses on delay (ICC (A) 2009 Clause 4.5 excludes delay even where the delay is caused by an insured peril, unless an endorsement specifies otherwise) are particularly relevant where regulatory clearance adds days to the journey. Importers should also consider single shipment marine cargo insurance for one-off high-value controlled substance movements that exceed standard open cover sub-limits, and the standalone specialist and high-value transit insurance placement for the high-value oncology and specialty biologics segment.

Frequently Asked Questions

Does the NPRA Import Licence cover controlled substances and scheduled poisons?

The NPRA Import Licence is the operational licence for importing registered products under the Sale of Drugs Act 1952. It does not by itself constitute authority to import controlled substances under the Dangerous Drugs Act 1952 or scheduled poisons or psychotropic substances under the Poisons Act 1952. Additional permits (Type A Poison Licence and per-consignment Section 20 or Section 30 Import Authorizations) are layered on top.

What is a Type A Poison Licence and why do importers need it?

The Type A Poison Licence is issued to a pharmacist under the Poisons Act 1952 and covers the import, storage, and dealing in all scheduled poisons (including Group A) by wholesale and retail, by wholesale only, or by retail only. Pharmaceutical importers handling scheduled poisons must appoint a Type A licence-holding pharmacist, and that pharmacist must be the person whose Identity Card or Passport is referenced on the NPRA Import Licence application where scheduled poisons are involved.

Can a Type B Licence cover Group A poisons?

No. Type B Licence, issued to a responsible officer of a company, expressly does not cover Group A poisons. Importers handling Group A poisons (the highest restriction scheduled poison category under the First Schedule of the Poisons Act 1952) must route the operation through a Type A licence-holding pharmacist.

What is the difference between the Dangerous Drugs Act 1952 and the Poisons Act 1952?

The Dangerous Drugs Act 1952 (Act 234) regulates opium, dangerous drugs, and related narcotics, with Section 20 setting the import authorisation regime. The Poisons Act 1952 (Act 366, revised 1989) regulates poisons listed in its First Schedule (the Poisons List, by Groups A to F) and psychotropic substances listed in its Third Schedule, with Section 30 and the Poisons (Psychotropic Substances) Regulations 1989 setting the authorisation regime for psychotropic substances. A given pharmaceutical product can fall within either Act, or both.

Do I need a separate Import Authorization for each shipment of psychotropic substance?

The Section 30 Import Authorization under the Poisons (Psychotropic Substances) Regulations 1989 is a per-consignment permit. Each individual import consignment of psychotropic substance requires its own authorisation in advance of shipment. The Pharmacy Enforcement Division of the Ministry of Health issues these authorisations.

Does the United Nations Convention on Psychotropic Substances 1971 apply to my shipments?

Where psychotropic substance cargo transits to Malaysia from a country that is a party to the Convention, the cargo must be accompanied by a valid and subsisting export authorisation issued by the competent authority of the exporting country. Malaysia's Section 30 Import Authorization is the domestic counterpart to that international obligation.

Are controlled substances covered under standard cargo insurance?

Standard pharmaceutical cargo policies frequently apply sub-limits to controlled substances under the Dangerous Drugs Act 1952 and Schedule 1 and Schedule 2 poisons under the Poisons Act 1952, or exclude them entirely unless a handling endorsement is purchased. Importers with mixed cargo should review controlled substances scope at placement, not at claim. The cargo insurance certificate should explicitly reference any controlled substances handling endorsement.

What documentation should travel with a controlled substance consignment?

The standard documentation pack is the applicable Section 20 Form C or Section 30 Import Authorization, the appointed pharmacist's Type A Poison Licence, the current NPRA Import Licence with the controlled substance on the listed annex, the originating country export authorisation where applicable, temperature monitoring records where the substance also falls within the cold chain regime, chain-of-custody handover records at every transshipment, and the cargo insurance certificate with the controlled substances endorsement explicitly written into the cover.

Voyage Conclusion

Controlled substances and scheduled poisons sit above the standard NPRA Import Licence regime and below specific Acts of Parliament administered by different parts of the Ministry of Health. The permit hierarchy stacks: MAL number, NPRA Import Licence, Type A Poison Licence pharmacist appointment, per-consignment Section 20 or Section 30 Import Authorization, and any conditions imposed on those authorisations. Standard cargo policies routinely sub-limit or exclude these categories, leaving the gap to surface at claim.

Talk to Voyage about Marine Cargo Open Cover for NPRA-licenced importers of controlled drugs and scheduled poisons, with controlled substances handling endorsements negotiated at placement. For high-value transits, Specialist High-Value Transit Insurance applies. For the industry view, see Pharmaceutical & Medical Devices Cargo Insurance. WhatsApp +60 19 990 2450 or use the contact form.

Take the Cargo Insurance Coverage Audit

Score your pharmaceutical cargo programme: Cargo Insurance Coverage Audit. Free, no signup wall.

Related in the pharmaceutical cluster: pharmaceutical imports cargo insurance cluster hub, NPRA import licence for pharmaceuticals, biologic drug transport in Malaysia, plus the broader foundational guides: Institute Cargo Clauses and LC insurance certificate requirements.

Disclaimer: This article provides general guidance on importing controlled substances and scheduled poisons into Malaysia as of May 2026. The framework is administered by the Pharmacy Enforcement Division and the National Pharmaceutical Regulatory Agency under the Dangerous Drugs Act 1952, the Poisons Act 1952, and related regulations. Substance-specific requirements may change; confirm current requirements with the Pharmacy Services Programme of the Ministry of Health before lodging an application.

Coverage terms, conditions, and availability vary by insurer, policy, and jurisdiction. Always review your specific policy wording and consult a qualified insurance or legal professional before making coverage decisions.